Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3.82M | $116.0M | 6.62% | +2.03M | 2026-03-31 |
| BlackRock, Inc. | 3.42M | $104.0M | 5.93% | +570.8K | 2026-03-31 |
| TANG CAPITAL MANAGEMENT LLC | 3.40M | $103.0M | 5.90% | +1.70M | 2026-03-31 |
| STATE STREET CORP | 2.18M | $66.0M | 3.78% | +1.35M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.03M | $61.0M | 3.52% | -- | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 1.51M | $45.0M | 2.61% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 1.44M | $43.0M | 2.50% | -429.0K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.12M | $34.0M | 1.94% | +101.0K | 2026-03-31 |
| DIADEMA PARTNERS LP | 1.03M | $31.0M | 1.79% | +361.2K | 2026-03-31 |
| JANE STREET GROUP, LLC | 1.01M | $30.0M | 1.75% | +911.9K | 2026-03-31 |
